Anatomic Stage I Breast Cancer AJCC v8
113
29
52
33
Key Insights
Highlights
Success Rate
63% trial completion
Published Results
14 trials with published results (12%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
16.8%
19 terminated out of 113 trials
63.5%
-23.0% vs benchmark
6%
7 trials in Phase 3/4
42%
14 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (113)
Breast Cancer, Reasoning, and Activity Intervention
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Breast Cancer Survivorship Biorepository
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial